Presented:

NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients

Read Now

Presented:

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Read Now

Presented:

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

Read Now

Presented:

NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter

Read Now

Presented:

NeoGenomics Provides COVID-19 Business Update

Read Now

Presented:

NeoGenomics Integrates HALO(R) From Indica Labs

Read Now

Presented:

NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020

Read Now

Presented:

NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization

Read Now

Presented:

NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference

Read Now

Presented:

NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter

Read Now